Elanco named Colle+McVoy as agency of record for its pain and surgery, dermatology and specialty brand portfolios. Colle+McVoy will lead strategic planning, creative, media planning, social media and
public relations for more than 12 companion animal health brands. The agency will also work on Elanco's global orthopedics and Canada business. The move to Colle+McVoy serves as an agency
consolidation of sorts, since Elanco acquired Novartis Animal Health in 2015 and worked with numerous agencies on more than 20 companion animal brands between Novartis and Elanco, a division of Eli
Lilly and Company. The agency picked up pain and surgery brands: Deramaxx, Adequan, Ethicon, Vetspon, Onsior and Recuvyra; dermatology brands: Atopica, Osurnia, Fresvio, Zobuxa and Surolan; and
specialty brands: Percorten-V and Clomicalm. "We were impressed with the breadth and depth of knowledge that the Colle+McVoy team has in animal health, which informs the insight-driven creative we
know will grow our business," said Jamie McDougall, director of marketing for Elanco's U.S. Companion Animal Business. Elanco spent $32.2 million on measured media in 2014 and $2 million on measured
media the first quarter of 2015, according to Kantar Media.
advertisement
advertisement